A Phase III randomised trial of intravesical chemotherapy vs. chemohyperthermiain intermediate risk non-muscle invasive bladder cancer
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 212
研究概览
简要总结
A Systematic Review of Regional Hyperthermia Therapy in Bladder Cancer. Thomas Andrew Longo, Ajay Gopalakrishna, Matvey Tsivian, Megan Van Noord, Coen R Rasch, Brant Inman, Debby Geijsen. International Journal of Hyperthermia. 2016 in press.
Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study. Geijsen ED, de Reijke TM, Koning CC, Zum Vörde Sive Vörding PJ, de la Rosette JJ, Rasch CR, van Os RM, Crezee J. J Urol. 2015 Nov;194(5):1202-8.
Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: technical feasibility study. Cordeiro ER, Geijsen DE, Zum Vörde Sive Vörding PJ, Schooneveldt G, Sijbrands J, Hulshof MC, de la Rosette J, de Reijke TM, Crezee H. J Endourol. 2013 Dec;27(12):1504-9
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with an intermediate risk non muscle invasive urothelial carcinoma of the bladder. For determination of the risk group the EAU scoring system will be used
- •performance status of 0 to 2
排除标准
- •Intravesical MMC during the last 6 months
- •Bladder tumours other than urothelial carcinoma